Related Experiment Videos
Contragestational agents. 1. Steroidal O-aryloximes.
Journal of Medicinal Chemistry
|December 1, 1977
Summary
Researchers developed novel steroid O-aryloximes for potential use as contraceptives. One compound effectively terminated pregnancy in rats without causing androgenic effects, showing promise for reproductive health applications.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Endocrinology
Background:
- Steroidal compounds have diverse biological activities.
- Developing novel agents for reproductive health is crucial.
- O-aryloxime derivatives offer a unique chemical scaffold.
Purpose of the Study:
- To synthesize and characterize a series of O-aryloximes of steroids.
- To evaluate the contragestational activity of these novel compounds in vivo.
- To identify specific structural features associated with potent anti-implantation effects.
Main Methods:
- Synthesis of O-aryloximes via two distinct chemical routes: keto steroid reactions with O-arylhydroxylamines or steroidal oxime reactions with aryl halides.
- In vivo testing of synthesized compounds for their ability to interrupt postimplantive gestation in female rats.
- Assessment of androgenic activity at effective contragestational doses.
Main Results:
- Successful preparation of various steroid O-aryloximes using acid-catalyzed or base-promoted reactions.
- Identification of 5alpha-androstane derivatives with 3-oxime p-nitrophenyl substitutions exhibiting significant contragestational activity.
- Compound (16) demonstrated potent pregnancy termination in rats at 2.5 mg/kg (days 9-12) with no observed androgenic activity.
Conclusions:
- Steroid O-aryloximes represent a promising class of compounds for interrupting pregnancy.
- The 5alpha-androstane scaffold with specific O-aryloxime substitutions is key for contragestational efficacy.
- The lead compound (16) offers a potential non-androgenic contraceptive agent.